Monocyte dysfunction in human cancer

Immunological factors which influence response to immunotherapy in malignant melanoma.

1970 • 462 citations

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

1973 • 221 citations

Immunologic alterations in bronchogenic cancer.Sequential Study

1968 • 190 citations

Abnormal Monocyte Chemotactic Response in Cancer Patients

1974 • 171 citations

Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cells

1977 • 166 citations

An Inhibitor of Macrophage Chemotaxis Produced by Neoplasms

1976 • 165 citations

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: Correlation with tumor stage and histology

1973 • 143 citations

Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course

1975 • 132 citations

Immunologic impairment in bronchogenic carcinoma: A study of lymphocyte response to phytohemagglutinin

1972 • 122 citations

Immunologic abnormalities in head and neck cancer

1974 • 105 citations

Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal2

1977 • 97 citations

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

1974 • 84 citations

Defective Monocyte Function in Patients With Genitourinary Carcinoma 2

1975 • 82 citations

Immunologic evaluation and prognosis in patients with head and neck cancer

1977 • 67 citations

Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors

1977 • 53 citations

Immunologic Status in Lung Cancer

1973 • 51 citations

Immune reactivity in primary carcinoma of the lung and its relation to prognosis

1976 • 44 citations

A qualitative and quantative study of monocytes in patients with malignant solid tumors

1978 • 43 citations

Quantitative assays of human moncyte-macrophage function

1975 • 42 citations

Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens

1973 • 41 citations

Monocytes and macrophages in malignant melanoma. II. Lysis of antibody-coated human erythrocytes as an assay of monocyte function

1978 • 31 citations

Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma

1976 • 30 citations

Suppressor Cells in Immunodepressed Bladder and Prostate Cancer Patients

1980 • 30 citations

Immunologic Testing as a Guide to Cancer Management

1979 • 29 citations

A prospective study of immune responsiveness in human melanoma.I. Assessment of initial pretreatment status with stage of disease

1978 • 28 citations

Discordance among Cell-Mediated Cytolytic Mechanisms in Cancer Patients: Importance of the Assay System

1979 • 26 citations

Immunobiology of Operable Breast Cancer

1976 • 26 citations

Counts and characteristics of macrophage precursors in human peripheral blood

1975 • 25 citations

Immunocompetence testing in patients with one of the four common operable cancers--a review.

1978 • 24 citations

Urine and blood serum muramidase (lysozyme) in patients with urogenital tumors

1971 • 21 citations

DEFECTIVE MACROPHAGE MIGRATION PRODUCED BY NEOPLASMS: IDENTIFICATION OF AN INHIBITOR OF MACROPHAGE CHEMOTAXIS11Supported in part by National Cancer Institute Contract No. NO1 CP 33313 and National Institute of Dental Research Grant 5 RO1 DE 03738-03.

1976 • 20 citations

Abnormal Monocyte Function in Bladder Cancer Patients

1976 • 20 citations

Blood Muramidase Activity in Colorectal Cancer

1974 • 15 citations

ROLE OF MACROPHAGES IN HOST DEFENSE MECHANISMS

1976 • 13 citations

Immunological monitoring in a controlled trial of immunotherapy in stage IIB malignant melanoma

1978 • 6 citations

Serum lysozyme in multiple myeloma.

1977 • 4 citations